MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,796 | -32.0% | 34,550 | 0.0% | 0.00% | – |
Q2 2023 | $158,585 | -3.8% | 34,550 | +3.8% | 0.00% | – |
Q1 2023 | $164,840 | -9.3% | 33,301 | 0.0% | 0.00% | – |
Q4 2022 | $181,823 | -17.5% | 33,301 | -1.8% | 0.00% | – |
Q3 2022 | $220,461 | +34.4% | 33,917 | -2.2% | 0.00% | – |
Q2 2022 | $164,036 | -60.9% | 34,680 | -42.2% | 0.00% | – |
Q1 2022 | $419,491 | -10.7% | 60,013 | +31.9% | 0.00% | – |
Q4 2021 | $470,000 | – | 45,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |